Weighted descriptive statistics, design-based F-tests, t-tests, and linear regression were used to assess associations between GLP-1 use and BMI, adjusting for demographics, insurance, cardiovascular disease, and year. This evidence concerns the gene GCG and cardiovascular disorder.